• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection

byBipandeep AbbatandAlex Chan
May 26, 2021
in Chronic Disease, Infectious Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

1. Among a large cohort from United States, infection with SARS-CoV-2 led to excess risk of developing new clinical sequelae, less commonly seen in other viral illnesses, after the acute phase of the infection.

Evidence Rating Level: 2 (Good)

In addition to the acute threat to life that the SARS-CoV-2 infection can pose to an infected individual, there is emerging literature suggesting that infection is additionally associated with significant long-term sequelae that can contribute to  increased morbidity and mortality worldwide. In this retrospective cohort study, researchers examined individuals aged 18 to 65, enrolled continuously in a health plan in 2019 – 2020, who were diagnosed with COVID-19 to further investigate the emergence of clinical sequalae following the acute phase of infection. The study utilized two control groups. The first comparator group were individuals aged 18 to 65, enrolled in a continuous health plan in 2019 or 2020, who were not diagnosed with COVID-19. There were 226 586 matched pairs made with this comparison group. The other comparator group included individuals aged 18 to 65, enrolled in a continuous health program in 2016, 2017 or 2018, who developed a viral-respiratory tract illness. The study matched 244 276 pairs with this comparison group. Examples of various sequelae included arrythmias, dermatitis, stroke, cardiomyopathy, hypercoagulability/deep vein thrombosis, kidney injury, seizures, and many more. All three comparator groups had lower rates of clinical sequelae develop, although the difference was smallest when compared to the viral lower respiratory tract group. The study found that 10.01% of individuals with COVID-19 developed new sequela after the acute phase of the infection and 4.01% had more than one type of sequelae. In the 2020 group, 7.08% of patients developed a clinical sequela (difference = 2.93%, p < 0.01) and 1.99% developed more than one type of sequelae (difference = 2.02%, p < 0.01). The 2019 group demonstrated that 7.36% of patients developed a clinical sequela (difference = 2.68%, p < 0.01) and 2.11% developed more than one sequela (difference = 1.91%, p < 0.01). In the viral lower respiratory tract matched groups, 10.38% of individuals with COVID-19 developed one sequela compared to 9.71% of those with another viral illness (difference = 0.68%, p < 0.01). 4.22% of individuals with COVID-19 developed more than one sequela compared to 3.25% of individuals with another viral illness (difference = 0.97%, p < 0.01). Finally, the study concluded that excess risk for developing clinical sequelae increased significantly with age. Several studies in the past have examined acute sequelae associated with COVID-19, however, this is one of the first large scale studies focusing on sequelae after the acute infection. The significant risk of sequelae development reported in the study provides valuable insight into the ongoing impact COVID-19 can have on a patient’s medical course, and is highly relevant for healthcare planning discussions.

Click to read the study in BMJ

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: SARS-CoV-2
Previous Post

#VisualAbstract: Primary trabeculectomy vs. medical management for advanced glaucoma have similar outcomes

Next Post

Electronic vapor product use in adolescents associated with increased sexual risk behaviors

RelatedReports

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients
StudyGraphics

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

June 30, 2022
Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males

June 22, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

May 13, 2022
Next Post
High schoolers use e-cigarettes to vaporize cannabis

Electronic vapor product use in adolescents associated with increased sexual risk behaviors

#VisualAbstract: Topical calcineurin inhibitor use is associated with an increased risk of lymphoma

#VisualAbstract: Topical calcineurin inhibitor use is associated with an increased risk of lymphoma

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Interventions to limit gestational weight gain associated with decreased risk of adverse pregnancy outcomes: US Preventive Services Task Force

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.